AstraZeneca and partner Moderna Therapeutics are heading to the lab for the first time together with their experimental cardiometabolic drug AZD8601.

The FDA has granted breakthrough therapy status to J&J and Genmab's Darzalex as a second-line treatment for multiple myeloma, positioning it for a…

Seattle startup Just Biotherapeutics has nabbed another $14 million to work on affordable biologics with a team lifted from Amgen as well as major backing…

The first spinoff from Cydan, an orphan disease incubator created by Pfizer Ventures and New Enterprise Associates, has nabbed $17 million to bump up its…

As the world’s top researchers working in Alzheimer’s disease descend into Toronto for the AAIC this week, all will be coming with a continued show of hope--…

California upstart Tricida has raised its highest level of cash to date with a $55 million Series C funding round backed by major biotech VC players.

Bristol-Myers Squibb will team up with AbbVie to run an early-stage lung cancer study combining BMS’ marketed checkpoint inhibitors with AbbVie’s experimental…

The FDA has designated Morphochem’s MCB3837 as a Qualified Infectious Disease Product and simultaneously put the antibiotic on its regulatory fast-track…